tiprankstipranks
Ascletis Pharma Debuts Dual-Method Obesity Drug Trials
PremiumCompany AnnouncementsAscletis Pharma Debuts Dual-Method Obesity Drug Trials
2M ago
Ascletis Pharma Reports Increased Loss and R&D Progress
Premium
Company Announcements
Ascletis Pharma Reports Increased Loss and R&D Progress
3M ago
Ascletis Pharma Forecasts Substantial Mid-Year Loss
Premium
Company Announcements
Ascletis Pharma Forecasts Substantial Mid-Year Loss
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100